Global Health Governance and the Fight against HIV And AIDS

The devastating effects of HIV/AIDS have propelled a multiplicity of activities at global, national and local level. This book is based on in-depth studies of the major global institutions in health, the role of pharmaceutical corporations, the functions of NGOs, and national responses to HIV/AIDS in two key case studies: Brazil and South Africa. Cover......Page 1 Contents......Page 8 List of Figures and Tables......Page 10 Foreword: Governing Interdependence......Page 11 Preface......Page 17 Notes on the Authors......Page 19 Abbreviations......Page 21 Introduction: Globalization, HIV/AIDS and the Rise of Global Health Governance......Page 26 1 Interfaces: a Concept for the Analysis of Global Health Governance......Page 43 2 Global Health Governance and WTO/TRIPS: Conflicts Between ‘Global Market-Creation’ and ‘Global Social Rights’......Page 63 3 From Conflict over Compromise to Cooperation? Big Pharma, the HIV/AIDS Crisis and the Rise of Countervailing Power in the South......Page 92 4 The Role of Civil Society Organizations in Global Health Governance......Page 117 5 International Governmental Organizations and Global Health Governance: the Role of the World Health Organization, World Bank and UNAIDS......Page 144 6 The Global Fund to Fight AIDS, Tuberculosis and Malaria......Page 171 7 Consensus-Building on Brazilian HIV/AIDS Policy: National and Global Interfaces in Health Governance......Page 197 8 The Treatment Controversy: Global Health Governance and South Africa’s Fight Against HIV/AIDS......Page 227 9 Conclusion: Global Health Governance and the Fight Against HIV/AIDS in a Post-Westphalian World......Page 251 Bibliography......Page 266 B......Page 296 C......Page 297 D......Page 298 G......Page 299 H......Page 300 I......Page 301 K......Page 302 N......Page 303 P......Page 304 S......Page 305 U......Page 306 W......Page 307 Cover 1 Contents 8 List of Figures and Tables 10 Foreword: Governing Interdependence 11 Preface 17 Notes on the Authors 19 Abbreviations 21 Introduction: Globalization, HIV/AIDS and the Rise of Global Health Governance 26 1 Interfaces: a Concept for the Analysis of Global Health Governance 43 2 Global Health Governance and WTO/TRIPS: Conflicts Between ‘Global Market-Creation’ and ‘Global Social Rights’ 63 3 From Conflict over Compromise to Cooperation? Big Pharma, the HIV/AIDS Crisis and the Rise of Countervailing Power in the South 92 4 The Role of Civil Society Organizations in Global Health Governance 117 5 International Governmental Organizations and Global Health Governance: the Role of the World Health Organization, World Bank and UNAIDS 144 6 The Global Fund to Fight AIDS, Tuberculosis and Malaria 171 7 Consensus-Building on Brazilian HIV/AIDS Policy: National and Global Interfaces in Health Governance 197 8 The Treatment Controversy: Global Health Governance and South Africa’s Fight Against HIV/AIDS 227 9 Conclusion: Global Health Governance and the Fight Against HIV/AIDS in a Post-Westphalian World 251 Bibliography 266 Index 296 A 296 B 296 C 297 D 298 E 299 F 299 G 299 H 300 I 301 J 302 K 302 L 303 M 303 N 303 O 304 P 304 Q 305 R 305 S 305 T 306 U 306 V 307 W 307 The HIV/AIDS pandemic poses one of the most crucial policy challenges of our times. Successfully managing this policy field is vital for saving millions of lives, improving national and international security, promoting economic development and contributing to poverty reduction. This collection systematically explores the global governance architecture surrounding HIV/AIDS. Examining key actors in global health - WHO, UNAIDS, The Global Fund, WTO/TRIPS, the pharmeceutical industry and civil society, it focuses on national responses to the pandemic in Brazil and South Africa - the two key countries that have significantly contributed to and shaped the discourse on global health. This book provides a theoretical understanding of the patterns of conflict and cooperation in the fight against HIV/AIDS and global health governance more broadly Based on in-depth studies of major global institutions in health dealing with HIV/AIDS, this title examines the role of pharmaceutical corporations, the functions of NGOs, and the national responses to HIV/AIDS in two key case studies, Brazil and South Africa